Australian Clinical Labs Ltd (AU:ACL) has released an update.
UBS Group AG has officially ceased to be a substantial shareholder in Australian Clinical Labs Ltd as of 19 July 2024, as detailed in their latest filing. This change follows their last update to the company on 22 July 2024. The specifics of the changes in voting securities and relevant interests are outlined in Appendix A of the notice.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.
